Faculty profile
James Christenson
Back to facultyThis profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Calgary directory, so their publications, courses and email address may be missing. Find their university profile.
Latest funding
- $4,048,545
A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of NoNO-42 in Participants with Acute Ischemic Stroke Selected for Thrombolysis
CIHR · 2023 · Principal investigator
- $1,012,136
A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of NoNO-42 in Participants with Acute Ischemic Stroke Selected for Thrombolysis
CIHR · 2023 · Principal investigator
A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of NoNO-42 in Participants with Acute Ischemic Stroke Selected for Thrombolysis
Principal investigators: Menon, Bijoy K; Christenson, James M; Hill, Michael D; Singh, Nishita; Swartz, Richard; Tymianski, Michael
Keywords: Acute; Neuro-Protection; Stroke; Thrombolysis
A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of NoNO-42 in Participants with Acute Ischemic Stroke Selected for Thrombolysis
Principal investigators: Menon, Bijoy K; Christenson, James M; Hill, Michael D; Singh, Nishita; Swartz, Richard; Tymianski, Michael
Keywords: Acute; Neuro-Protection; Stroke; Thrombolysis
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.